Yi‐Han Chiu

1.0k total citations
44 papers, 843 citations indexed

About

Yi‐Han Chiu is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yi‐Han Chiu has authored 44 papers receiving a total of 843 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yi‐Han Chiu's work include Epigenetics and DNA Methylation (6 papers), Autophagy in Disease and Therapy (5 papers) and Plasma Applications and Diagnostics (4 papers). Yi‐Han Chiu is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), Autophagy in Disease and Therapy (5 papers) and Plasma Applications and Diagnostics (4 papers). Yi‐Han Chiu collaborates with scholars based in Taiwan, United States and India. Yi‐Han Chiu's co-authors include Kuang‐Wen Liao, Kuo‐Chin Huang, Chia‐Jung Li, Chang‐Jer Wu, Tse‐Hung Huang, Tsung‐Lin Li, Yi-Lin Chan, Kuo‐Chin Huang, Chen‐Si Lin and Kuang‐Hung Hsu and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Agricultural and Food Chemistry and International Journal of Molecular Sciences.

In The Last Decade

Yi‐Han Chiu

43 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi‐Han Chiu Taiwan 19 349 105 95 93 92 44 843
Yujia Zhou China 15 341 1.0× 110 1.0× 156 1.6× 113 1.2× 87 0.9× 46 767
Jia Zhou China 19 319 0.9× 73 0.7× 52 0.5× 187 2.0× 130 1.4× 61 921
Jestin Chellian Malaysia 16 275 0.8× 52 0.5× 67 0.7× 53 0.6× 47 0.5× 31 799
Janina Didžiapetrienė Lithuania 16 252 0.7× 163 1.6× 149 1.6× 113 1.2× 76 0.8× 67 897
Weisen Zeng China 14 525 1.5× 170 1.6× 50 0.5× 126 1.4× 60 0.7× 39 981
Yuan Huang China 17 357 1.0× 117 1.1× 149 1.6× 62 0.7× 43 0.5× 55 891
Zhenhao Li China 23 591 1.7× 126 1.2× 96 1.0× 173 1.9× 134 1.5× 71 1.3k
Haining Tan China 17 360 1.0× 70 0.7× 30 0.3× 53 0.6× 45 0.5× 51 888
Shijia Liu China 21 533 1.5× 83 0.8× 40 0.4× 109 1.2× 57 0.6× 75 1.2k
Yu‐Chi Chen China 19 465 1.3× 114 1.1× 107 1.1× 297 3.2× 115 1.3× 66 1.1k

Countries citing papers authored by Yi‐Han Chiu

Since Specialization
Citations

This map shows the geographic impact of Yi‐Han Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Han Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Han Chiu more than expected).

Fields of papers citing papers by Yi‐Han Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi‐Han Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Han Chiu. The network helps show where Yi‐Han Chiu may publish in the future.

Co-authorship network of co-authors of Yi‐Han Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi‐Han Chiu. A scholar is included among the top collaborators of Yi‐Han Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi‐Han Chiu. Yi‐Han Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Yi-Lin, James C. Liao, Tsung‐Lin Li, Chang‐Jer Wu, & Yi‐Han Chiu. (2025). Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions. Applied Microbiology and Biotechnology. 109(1). 69–69. 1 indexed citations
2.
Chiu, Yi‐Han, Wei-Ling Chou, Mei‐Lan Ko, James C. Liao, & Tse‐Hung Huang. (2025). Curcumin mitigates obesity-driven dysbiosis and liver steatosis while promoting browning and thermogenesis in white adipose tissue of high-fat diet-fed mice. The Journal of Nutritional Biochemistry. 143. 109920–109920. 7 indexed citations
3.
Chiu, Yi‐Han, et al.. (2023). Effects of a 12-week walking intervention on circulating lipid profiles and adipokines in normal weight and abdominal obese female college students. Journal of Exercise Science & Fitness. 21(3). 253–259. 4 indexed citations
5.
Li, Chia‐Jung, Li‐Te Lin, Pei‐Yi Chu, et al.. (2021). Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer. Journal of Personalized Medicine. 11(4). 316–316. 17 indexed citations
6.
Li, Chia‐Jung, Yi‐Han Chiu, Chung Chang, et al.. (2021). Acetyl Coenzyme A Synthase 2 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Cervical Squamous Cell Carcinoma. Cancers. 13(13). 3125–3125. 32 indexed citations
7.
Tsai, Nu‐Man, et al.. (2021). Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers. Cancer Control. 28. 2895427293–2895427293. 13 indexed citations
9.
Chiu, Yi‐Han, et al.. (2019). Dovitinib Triggers Apoptosis and Autophagic Cell Death by Targeting SHP-1/p-STAT3 Signaling in Human Breast Cancers. Journal of Oncology. 2019. 1–14. 8 indexed citations
11.
Huang, Kuo‐Chin, et al.. (2016). Prophylactic acetylsalicylic acid attenuates the inflammatory response but fails to protect exercise-induced liver damage in exercised rats. European Journal of Pharmacology. 786. 204–211. 4 indexed citations
12.
Lin, Yu‐Ling, Nu‐Man Tsai, Hsin-Yi Wu, et al.. (2012). Inhibitory Effects of Chloroform Extracts Derived from Corbicula fluminea on the Release of Pro-inflammatory Cytokines. Journal of Agricultural and Food Chemistry. 60(16). 4076–4082. 21 indexed citations
13.
Liao, Kuang‐Wen, et al.. (2012). Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch. International Journal of Nanomedicine. 7. 607–607. 21 indexed citations
14.
Lin, Yu‐Ling, Chia‐Hung Chen, Hsin‐Yi Wu, et al.. (2011). 7,7′′‐Dimethoxyagastisflavone‐induced Apoptotic or Autophagic Cell Death in Different Cancer Cells. Phytotherapy Research. 26(4). 528–534. 10 indexed citations
15.
Jou, Shyankay, et al.. (2011). Enhancement of VUV Emission from a Coaxial Xenon Excimer Ultraviolet Lamp Driven by Distorted Bipolar Square Voltages. Contributions to Plasma Physics. 51(10). 906–919. 2 indexed citations
16.
Subeq, Yi‐Maun, et al.. (2011). Recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats. Injury. 43(3). 367–373. 31 indexed citations
17.
Chiu, Yi‐Han. (2010). The anti-cancer efficacy of curcumin scrutinized through core signaling pathways in glioblastoma. International Journal of Molecular Medicine. 26(2). 217–24. 45 indexed citations
18.
Subeq, Yi‐Maun, et al.. (2010). Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats. Cytokine. 53(2). 223–230. 28 indexed citations
19.
20.
Wu, Ming‐Shiang, Jaw‐Town Lin, Ping‐Ning Hsu, et al.. (2007). Preferential Induction of Transforming Growth Factor–β Production in Gastric Epithelial Cells and Monocytes byHelicobacter pyloriSoluble Proteins. The Journal of Infectious Diseases. 196(9). 1386–1393. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026